Medicross Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.70 Cr
as on 22-05-2024
- Paid Up Capital ₹ 4.99 M
as on 22-05-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.89 Cr
as on 22-05-2024
- Satisfied Charges ₹ 0.45 M
as on 22-05-2024
- Revenue 45434.50%
(FY 2023)
- Profit 18981.20%
(FY 2023)
- Ebitda 48516.37%
(FY 2023)
- Net Worth 10155.15%
(FY 2023)
- Total Assets 14541.13%
(FY 2023)
About Medicross Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.70 Cr and a paid-up capital of Rs 4.99 M.
The company currently has active open charges totaling ₹12.89 Cr. The company has closed loans amounting to ₹0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Singh, Askand Krishna, Shweta Singh, and Three other members serve as directors at the Company.
- CIN/LLPIN
U51397MH1996PTC101063
- Company No.
101063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 1996
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medicross Laboratories?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Singh  | Director | 17-Jan-2020 | Current |
| Ram Singh | Director | 15-Jul-1996 | Current |
| Askand Krishna | Director | 20-Dec-2021 | Current |
| Shweta Singh | Director | 20-Mar-2018 | Current |
| Sunita Singh | Director | 20-Mar-2018 | Current |
| Abhilasha Singh | Director | 20-Mar-2018 | Current |
Financial Performance of Medicross Laboratories.
Medicross Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 45434.5% increase. The company also saw a substantial improvement in profitability, with a 18981.2% increase in profit. The company's net worth Soared by an impressive increase of 10155.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medicross Laboratories?
Unlock access to Medicross Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Sep 2023 | ₹4.49 Cr | Open |
Axis Bank Limited Creation Date: 24 Jul 2023 | ₹4.49 Cr | Open |
Bank Of India Creation Date: 29 Sep 2021 | ₹3.90 Cr | Open |
How Many Employees Work at Medicross Laboratories?
Unlock and access historical data on people associated with Medicross Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medicross Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicross Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
